Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.56
+0.09 (0.27%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Agios Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $45.75. The average 1-year stock price forecast is 36.32% higher than the current stock price, while the lowest is $32 (-4.65%) and the highest is $73 (+117.52%).
Price Target: $45.75 (+36.32%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 4, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $32 | Hold | Maintains | $32 | -4.65% | Jul 31, 2026 |
| Citi | Citi | Buy Maintains $46 → $52 | Buy | Maintains | $46 → $52 | +54.95% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $46 | Buy | Reiterates | $46 | +37.07% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
182.49M
from 54.03M
Increased by 237.78%
Revenue Next Year
339.85M
from 182.49M
Increased by 86.22%
EPS This Year
-5.66
from -7.12
EPS Next Year
-4.19
from -5.66
EPS and Forward PE are based on non-GAAP adjusted numbers.